A61K 9/0078
For inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer
Official title: {for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions}
A61K9/0078 (For inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer) appears on 1,118 US grants and 2,403 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,118
- Published applications
- 2,403
- Assignees
- 901
- Inventors
- 3,242
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 7 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 7 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 10 | 0 |
| 1998 | 9 | 0 |
| 1999 | 15 | 0 |
| 2000 | 15 | 0 |
| 2001 | 10 | 8 |
| 2002 | 21 | 33 |
| 2003 | 16 | 57 |
| 2004 | 12 | 43 |
| 2005 | 13 | 62 |
| 2006 | 18 | 43 |
| 2007 | 13 | 79 |
| 2008 | 15 | 45 |
| 2009 | 18 | 67 |
| 2010 | 21 | 80 |
| 2011 | 21 | 52 |
| 2012 | 33 | 74 |
| 2013 | 34 | 70 |
| 2014 | 49 | 78 |
| 2015 | 43 | 92 |
| 2016 | 51 | 94 |
| 2017 | 57 | 102 |
| 2018 | 47 | 85 |
| 2019 | 60 | 115 |
| 2020 | 55 | 146 |
| 2021 | 71 | 199 |
| 2022 | 78 | 160 |
| 2023 | 74 | 213 |
| 2024 | 80 | 161 |
| 2025 | 69 | 163 |
| 2026 | 50 | 82 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for delivery of psychedelic medications by inhalation and systems for performing the methods6 Oct 2026US 12,751,940 B2Cybin IRL Limited
- Bacteriophage compositions for treating Staphylococcus infection6 Oct 2026US 12,751,983 B2Armata Pharmaceuticals, Inc.
- Immunostimulatory adjuvants6 Oct 2026US 12,752,000 B2Orionis Biosciences BV
- Nanosuspension formulation for treatment of pulmonary fibrosis29 Sep 2026US 12,746,210 B2Federal University of Rio De Janeiro
- Treatment for interstitial lung disease22 Sep 2026US 12,740,954 B2United Therapeutics Corporation
- Steroid-cationic lipid compound and use thereof8 Oct 2026US 2026/0306406 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Biologically compatible, biofilm disrupting composition and methods1 Oct 2026US 2026/0294861 A1
- Sterile formulation of an anesthetic and bronchodilator17 Sep 2026US 2026/0272828 A1
Most cited
By later US patents
- Method and apparatus for administering dehydrated liposomes by inhalation353US 4,895,719 ALiposome Technology, Inc. · 1990
- Small particle aerosol liposome and liposome-drug combinations for medical use277US 5,049,388 AResearch Development Foundation · 1991
- Novel liposome composition for the treatment of interstitial lung diseases259US 5,049,389 ALiposome Technology, Inc. · 1991
- Methods and devices for treating plumonary vasoconstriction and asthma251US 5,485,827 AThe General Hospital Corporation · 1996
- Pulmonary administration of granulocyte colony stimulating factor245US 5,284,656 AAmgen Inc. · 1994